Cork, Ireland (ots/PRNewswire) - -INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside ...
Astellas Pharma Europe Limited
Staines, England (ots/PRNewswire) - - Not for distribution in the United Kingdom - Research Adds to Already Demonstrated Efficacy in Adult Population Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment ...
Washington (ots/PRNewswire) - Crude oil prices "could" fall below US$100 per barrel over the next 18 months on slowing worldwide demand and an increase in oil production, Energy Information Administration (EIA) chief Guy Caruso said Tuesday. Caruso made the comment to reporters at the Platts Energy Podium in Washington. "I think [prices] could fall below US$100 a barrel on slowing global demand and rising ...
Laval, Canada (ots/PRNewswire) - The Laval-based firm Algorithme Pharma is pleased to announce that it has achieved its goal of securing a European facility through its acquisition of Simbec Research Ltd in Merthyr Tydfil, Wales. This news comes only six weeks after confirming the purchase of another clinical ...
Calgary, Canada (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) is pleased to announce that the Phase 1b/2a program for the study of RVX-208 in subjects with normal lipids and those with low high-density lipoprotein (HDL) cholesterol has proceeded according to plan. "We are very excited about moving forward into this important 28-day study with RVX-208. Our previous clinical study ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the production availability of its new AT25DF081, the industry's first 8-megabit Serial Flash device capable of operating at 1.8-volts. With a low-voltage operating range of 1.65V to 1.95V, the AT25DF081 operates at the same voltage range as many current and ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICS) (ICX:TSX.V) is pleased to announce the appointment of Mr. Richard Molyneux to the position of Chairman of the Board of Directors. The Company wishes to express its gratitude to the outgoing Chairman, Mr. Mel Smale, who will stay on as a Director. Mr. Smale has been the Chairman of ICS since the Company went public and has served the ...
Indianapolis (ots/PRNewswire) - - Study with duloxetine evaluating long-term pain reduction in treatment of DPNP is first to exceed three months Duloxetine hydrochloride maintained pain reduction in the treatment of diabetic peripheral neuropathic pain (DPNP) for more than six months,(1) according to new ...
Petit-Lancy (ots) - - July retails sales up 28 percent - 220,500 units January-July highest volume in company history - 17 countries up in July, 15 countries with double-digit growth ots Originaltext: Mazda (Suisse) SA Internet: www.presseportal.ch/fr Contact: Mazda (Suisse) SA Giuseppe Loffredo PR Director Tel.: +41/22/719'33'60 E-Mail: gloffredo@mazda.ch Internet: ...
London (ots/PRNewswire) - Platts -- The Organization of the Petroleum Exporting Countries' (OPEC) 13 members boosted their collective crude oil production by 300,000 barrels per day (b/d) in July to average 32.77 million b/d over the month, according to a Platts survey of OPEC and oil industry officials just released. Excluding Iraq, the 12 members bound by ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today that it supports a new text-based information service for digital broadcasting, called Journaline(R), which will be integrated into several shuttle vehicles at the 2008 Summer Olympics in China. This service delivers ...
Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) ...
Premier Muzik International Corporation
Montreal (ots/PRNewswire) - Gino Olivieri, founder of Premier Muzik International Corporation, a Montreal company that administers and redistributes royalties to such artists as Red Hot Chili Peppers, Metallica, Bob Sinclar and Andrea Bocelli, has realized one of his fondest dreams by becoming the winning bidder ...
Vancouver (ots/PRNewswire) - Oremex Resources Inc. (TSX-V: ORM) (the Company) today provided a progress update for the Tejamen Silver Property (Tejamen). The Company has generated significant support for development of Tejamen from State, regional and local officials as well as the commercial, health, educational and regional sectors and the general populace of Tejamen and Nuevo Ideal. In addition, the Federal Minister of Mines has dedicated staff to assist with ...
Mexico City (ots/PRNewswire) - - HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar ...
Mexico City, Mexico (ots/PRNewswire) - - Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008 New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company's once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults ...
Basel, Switzerland (ots/PRNewswire) - - Submission Based on Phase III Study Showing Superior Results for MabThera in Chronic Lymphocytic Leukaemia (CLL) When Added to Standard Chemotherapy Today, Roche submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for the use of its biotechnology drug MabThera (rituximab) as ...
Chicago (ots/PRNewswire) - - Findings lead to decision to start Phase III pivotal study of LY2062430 in 2009 Eli Lilly and Company (NYSE: LLY) today announced interim results of its Phase II study of LY2062430, an investigational anti-amyloid beta monoclonal antibody for the treatment of mild to ...
Calgary (ots/PRNewswire) - - Submission Demonstrates Progress of Plant-Derived Insulin Program Scheduled to Enter the Clinic Later This Year SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it has submitted an Investigational New Drug ...
Paris (ots/PRNewswire) - - Net Income up by 41% - Fourth Consecutive Quarter of Margin Improvement - Debt Reduction of 178 Million Euros - Good Level of Order Intake Valeo's Board of Directors, which met yesterday, approved the consolidated financial summary for the first half 2008. 1st half** Quarterly change in 2008 In million euros 2nd 1st ...
Dar Es Salaam, Tanzania (ots/PRNewswire) - - Partnership Will Modernize All Regional Hospital Laboratories to Improve Access to Care Across the Country At a ceremony today, the Ministry of Health and Social Welfare, United Republic of Tanzania, and Abbott Fund commemorated the latest step in a nationwide ...
Paris (ots/PRNewswire) - On 24 June, Justin Timberlake made an exclusive appearance in Paris for Parfums Givenchy at the press presentation of Givenchy's new men's fragrance. Timberlake is the face of the new scent, which will go on sale in September 2008, and is featured in the two advertising visuals for the brand. Multimedia News Release - http://www.prnewswire.com/mnr/givenchy/34164/ The American star's ...
Paris and Copenhagen, Denmark (ots/PRNewswire) - In a statement following the final results of this year's Tour de France, the two founders of Saxo Bank and joint CEOs, Kim Fournais and Lars Seier Christensen, praised the Team CSC Saxo Bank and said that with this Tour the cycling sport had reached a turning point. "Watching Carlos Sastre in the Yellow Jersey and Andy Schleck in the White, side by side, today, ...
Basel, Switzerland (ots/PRNewswire) - The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche's Viracept (nelfinavir mesylate) did not increase patients' risk of developing cancer. The discovery of the EMS impurity ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to announce that the Company has obtained important assays and widths from the sulphide twinning confirmation diamond drill program which is now completed. The latest results show that hole m-08-s-04 intersected 40.9 meters true thickness of 1.10% total copper and hole ...
Dublin, Ireland (ots) - Helsinn is pleased to announce that Helsinn Birex Pharmaceuticals, its drug facility in Dublin Ireland, has undergone a successful inspection by the US Food and Drug Administration (FDA) without any Form 483 observations. The FDA visit, which lasted 5 days, was a pre-approval inspection ...
University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit
London (ots/PRNewswire) - The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed that the hypothesis-generating results of the SEAS trial of ezetimibe should be tested by reviewing the combined cancer results from the SHARP and IMPROVE-IT trials of ezetimibe, and reporting on the overall findings to the relevant ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - In the news release, "Update on the SEAS Study" issued on 21 Jul 2008 07:00 GMT, by Prof Terje Pedersen,SEAS Study Principal Investigator & Head of Steering Committee over PR Newswire, we are advised by a representative of the organisation that the following information has been ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - Professor Terje Pedersen (Ullevål University Hospital, Oslo, Norway), lead investigator for the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will provide an update on the study on Monday the 21st July. Also present in London will be Sir Richard Peto (Professor of Medical Statistics and Epidemiology and Co-director of the Clinical Trials Service Unit, University of Oxford) Professor Rory Collins (BHF Professor of Medicine and ...